, /PRNewswire/ -- Life Seal Vascular Inc. ), a pioneering company dedicated to revolutionizing endovascular treatment, is thrilled to announce that it has been awarded the highly competitive National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant. This funding will accelerate the development of Life Seal Vascular's cutting-edge technology to improve patient outcomes and advance the field of endovascular aortic repair (EVAR).
"We are honored to receive this prestigious SBIR grant from the NSF. This funding is a testament to the innovative potential of our technology and our commitment to advancing EVAR care," said , Executive Chairman of the Board at Life Seal Vascular Inc. "With this support, we are well-positioned to advance the development of our breakthrough aneurysm sealing solutions and make a significant impact on the lives of EVAR patients worldwide.
" The NSF SBIR grant will enable Life Seal Vascular to further develop its proprietary aneurysmal sac sealing technology. Designed as an adjunctive therapy to native endografts, Life Seal Vascular's groundbreaking approach seals the entire aneurysmal sac potentially eliminating endoleaks, reducing reintervention rates and improving clinical outcomes for EVAR patients. Dr.
, a renowned vascular surgeon, commented on the significance of Life Seal Vascular's technology, stating, "The advancements being made by Life Seal Vascular are truly remarkable. Their innovative solutions have the potential to re.